Margaret A Lampe

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Human immunodeficiency virus-1 and preconception care
    Margaret A Lampe
    U S Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Epidemiology Branch, Mother Child Transmission Team, Atlanta, Georgia, USA
    Matern Child Health J 10:S193-5. 2006
  2. ncbi request reprint Toward elimination of perinatal human immunodeficiency virus transmission in the United States: effectiveness of funded prevention programs, 1999-2001
    Stephanie L Sansom
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Information Technology Support, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S90-5. 2007
  3. doi request reprint Factors associated with declining a rapid human immunodeficiency virus test in labor and delivery
    Kathrine R Tan
    Division of Parasitic Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Matern Child Health J 15:115-21. 2011
  4. doi request reprint Testing women for human immunodeficiency virus infection: who, when, and how?
    Jill Clark
    Northrop Grumman Information Technology, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:507-17. 2008
  5. pmc HIV screening practices in U.S. hospitals, 2009-2010
    Andrew C Voetsch
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Atlanta, GA 30333, USA
    Public Health Rep 127:524-31. 2012
  6. ncbi request reprint Cesarean delivery for HIV-infected women: recommendations and controversies
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S96-100. 2007
  7. ncbi request reprint Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001
    Norma S Harris
    Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV AIDS Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 197:S33-41. 2007
  8. ncbi request reprint Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S26-32. 2007
  9. doi request reprint Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico
    Suzanne K Whitmore
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 129:e74-81. 2012
  10. pmc False-positive human immunodeficiency virus enzyme immunoassay results in pregnant women
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e16538. 2011

Detail Information

Publications17

  1. pmc Human immunodeficiency virus-1 and preconception care
    Margaret A Lampe
    U S Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Epidemiology Branch, Mother Child Transmission Team, Atlanta, Georgia, USA
    Matern Child Health J 10:S193-5. 2006
  2. ncbi request reprint Toward elimination of perinatal human immunodeficiency virus transmission in the United States: effectiveness of funded prevention programs, 1999-2001
    Stephanie L Sansom
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Information Technology Support, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S90-5. 2007
    ..24). The number of perinatal HIV infections in the funded areas decreased by 56%, achieving the Centers for Disease Control and Prevention's goal of a 50% reduction in incidence by 2005...
  3. doi request reprint Factors associated with declining a rapid human immunodeficiency virus test in labor and delivery
    Kathrine R Tan
    Division of Parasitic Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Matern Child Health J 15:115-21. 2011
    ..Documentation and timely communication of HIV status is critical to provide appropriate HIV prophylaxis...
  4. doi request reprint Testing women for human immunodeficiency virus infection: who, when, and how?
    Jill Clark
    Northrop Grumman Information Technology, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:507-17. 2008
    ..These recommendations are described separately for general populations (including nonpregnant women) and for pregnant women and their infants...
  5. pmc HIV screening practices in U.S. hospitals, 2009-2010
    Andrew C Voetsch
    Centers for Disease Control and Prevention, Division of HIV AIDS Prevention, Atlanta, GA 30333, USA
    Public Health Rep 127:524-31. 2012
    ..In 2006, the Centers for Disease Control and Prevention (CDC) recommended HIV screening for all individuals 13-64 years of age in health-care settings. We determined the frequency of hospital adoption of these CDC recommendations...
  6. ncbi request reprint Cesarean delivery for HIV-infected women: recommendations and controversies
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S96-100. 2007
    ..However, a number of important questions remain unanswered, including whether cesarean delivery has a role among HIV-infected women with low plasma viral loads or who receive combination antiretroviral regimens...
  7. ncbi request reprint Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001
    Norma S Harris
    Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV AIDS Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 197:S33-41. 2007
    ..Significant reductions in perinatal human immunodeficiency virus (HIV) transmission have been demonstrated in which the HIV-infected mothers and their HIV-exposed infants receive prenatal, intrapartum, and neonatal antiretroviral therapy...
  8. ncbi request reprint Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S26-32. 2007
    ..For women with HIV RNA levels of < 1000 copies/mL, a 3-part zidovudine prophylaxis regimen (prenatal, intrapartum, and neonatal) should be used alone or in combination with other antiretroviral drugs...
  9. doi request reprint Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico
    Suzanne K Whitmore
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 129:e74-81. 2012
    ..The goal of this study was to examine associations between demographic, behavioral, and clinical variables and mother-to-child HIV transmission in 15 US jurisdictions for birth years 2005 through 2008...
  10. pmc False-positive human immunodeficiency virus enzyme immunoassay results in pregnant women
    Laura G Wesolowski
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e16538. 2011
    ..Examine whether false-positive HIV enzyme immunoassay (EIA) test results occur more frequently among pregnant women than among women who are not pregnant and men (others)...
  11. doi request reprint Achieving safe conception in HIV-discordant couples: the potential role of oral preexposure prophylaxis (PrEP) in the United States
    Margaret A Lampe
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 204:488.e1-8. 2011
    ..Anecdotal reports suggest that oral preexposure prophylaxis use is already occurring. It is time to have open discussions of when and how preexposure prophylaxis might be indicated for HIV-discordant couples attempting conception...
  12. doi request reprint A framework for elimination of perinatal transmission of HIV in the United States
    Steven Nesheim
    Centers for Disease Control and Prevention, MS E 45, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 130:738-44. 2012
    ..It is emphasized that EMCT will not be a one-time accomplishment but, rather, will require sustained effort as long as there are new HIV infections in women of childbearing age...
  13. ncbi request reprint Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience
    Denise J Jamieson
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S72-82. 2007
    ..Routine rapid testing during labor provides a feasible, acceptable, and accurate way to identify HIV-infected women before delivery...
  14. ncbi request reprint Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings
    Bernard M Branson
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-17; quiz CE1-4. 2006
    ..Repeat screening in the third trimester is recommended in certain jurisdictions with elevated rates of HIV infection among pregnant women...
  15. ncbi request reprint Achieving universal HIV screening in prenatal care in the United States: provider persistence pays off
    John E Anderson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Patient Care STDS 19:247-52. 2005
    ..This training should emphasize the importance of routine testing. Even with the opt-out approach, many women may decline testing if their doctor does not recommend and encourage HIV testing...
  16. ncbi request reprint Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions
    Mary Glenn Fowler
    Department of Pathology, Johns Hopkins Medical School, onsite Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    Am J Obstet Gynecol 197:S3-9. 2007
    ..The challenges to eliminate new perinatal HIV infections worldwide will depend on both sustaining and expanding PMTCT interventions and effective primary HIV prevention for women, adolescents, and young adults...
  17. ncbi request reprint An end to perinatal HIV: success in the US requires ongoing and innovative efforts that should expand globally
    Carolyn K Burr
    Fran├žois Xavier Bagnoud Center, University of Medicine and Dentistry of New Jersey, Newark 07103, USA
    J Public Health Policy 28:249-60. 2007
    ..Successful approaches that have nearly eliminated perinatal HIV transmission in the United States offer valuable lessons that should be applied to primary HIV prevention for women in the United States and globally...